10 completed, 7 recruiting, 3 not yet recruiting, 2 terminated. 19 Not applicable, 3 Phase 1, 2 Phase 2, 2 Phase 3.
Follow Chemotherapy-induced Peripheral Neuropathy (CIPN): new trials by email Literature Review of Chemotherapy-induced Peripheral Neuropathy (CIPN) trials Research Report on Chemotherapy-induced Peripheral Neuropathy (CIPN)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AYUrvedic Foot Massage for Symtoms of Taxane-induced Peripheral nEuroPathy Manual manipulation of the feet. - Chemotherapy-induced Peripheral Neuropathy (CIPN) | Not applicable | Not yet recruiting | European Institute of Oncology | 20 | 2026-10-01 | 2026-10-20 |
| Efficacy of Spinal Cord Stimulation in Chemotherapy-Induced Peripheral Neuropathy Spinal cord stimulation (FAST mode), Sham Spinal Cord Stimulation - Neuropathic Pain, Chemotherapy-induced Peripheral Neuropathy (CIPN) | Not applicable | Not yet recruiting | Assistance Publique Hopitaux De Marseille | 68 | 2026-09-01 | 2026-05-12 |
| Electroacupuncture and Exercise for Chemotherapy-Induced Peripheral Neuropathy (CIPN) Electroacupuncture, Exercise Training, Structured Home-Based Health Education and Dose-Controlled Exercise Program - Cancer, Chemotherapy-induced Peripheral Neuropathy (CIPN) | Not applicable | Recruiting | Show Chwan Memorial Hospital | 82 | 2026-07-23 | 2026-08-28 |
| Effectiveness of Video-Based Movement Analysis-Guided Personalized Rehabilitation in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN) ReMap, Usual Care - Chemotherapy-induced Peripheral Neuropathy (CIPN) | Not applicable | Enrolling by invitation | Seoul National University Bundang Hospital | 150 | 2026-06-30 | 2026-08-14 |
| Safety, Tolerability, and PK of AH-008 Following Single Ascending Dose in Healthy Subjects AH-008 for Injection, 150 mg, AH-008 for Injection, Placebo - Chemotherapy-induced Peripheral Neuropathy (CIPN) | Phase 1 | Completed | AnHorn Medicines Co. Ltd. | 32 | 2026-06-10 | 2026-10-29 |
| Trial of a Virtual Exercise-based Rehabilitation Program to Treat Persistent Chemotherapy-Induced Peripheral Neuropathy (CIPN) EX-CIPN - Chemotherapy-induced Peripheral Neuropathy (CIPN) | Phase 3 | Recruiting | University Health Network, Toronto | 240 | 2026-03-30 | 2026-06-05 |
| Otago Exercise Program in Chemotherapy Induced Peripheral Neuropathy Otago Exercise Program, Resistance Exercise - Chemotherapy-induced Peripheral Neuropathy (CIPN) | Not applicable | Completed | Cairo University | 48 | 2026-01-01 | 2026-08-19 |
| Acupuncture and Compression for the Prevention of CIPN in Breast Cancer Patients Compression, Acupuncture, Sham acupuncture - Breast Cancer, Chemotherapy-induced Peripheral Neuropathy (CIPN) | Not applicable | Recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 384 | 2025-09-01 | 2026-02-02 |
| Relationship Between Great Toe Strength And Symptoms of Chemotherapy-Induced Peripheral Neuropathy (CIPN) No intervention (observational study) - Chemotherapy-induced Peripheral Neuropathy (CIPN), Healthy | Recruiting | University of Florida | 30 | 2025-08-05 | 2026-11-03 | |
| GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer GM1, Placebo - Chemotherapy-induced Peripheral Neuropathy (CIPN) | Phase 3 | Recruiting | Qilu Pharmaceutical Co., Ltd. | 352 | 2025-08-01 | 2025-08-06 |
| Web-Based Exercise for Neuropathy and Quality of Life in Breast Cancer Web-Based Exercise Program - Chemotherapy-Induced Peripheral Neuropathy (CIPN), Breast Cancer | Not applicable | Completed | Bilecik Seyh Edebali Universitesi | 95 | 2025-05-28 | 2026-09-14 |
| Topical Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy menthol-based hand and foot gloves, Sham menthol-based hand and foot gloves - Chemotherapy-induced Peripheral Neuropathy (CIPN) | Phase 2 | Active not recruiting | Taiwan Municipal An-Nan Hospital-China Medical University | 40 | 2025-05-12 | 2026-07-09 |
| Effect of Adding Electroacupuncture to Anti-cancer Therapy-induced Peripheral Neuropathy True acupuncture + standard anti chemotherapy-induced peripheral neuropathy treatment, Sham acupuncture +standard anti chemotherapy-induced peripheral neuropathy treatment - Chemotherapy-induced Peripheral Neuropathy (CIPN), Cancer | Not applicable | Recruiting | Zhongnan Hospital | 150 | 2025-03-20 | 2025-04-20 |
| Use of PEA and Scutellaria in Synergy With Therapeutic Exercise in Chemotherapy-induced Peripheral Neuropathy (CIPN): a Clinical Trial Chemotherapy-induced Peripheral Neuropathy (CIPN), Neuropathic Pain | Recruiting | University of Palermo | 40 | 2025-03-15 | 2026-01-20 | |
| Heat and Cold Therapy for Chemotherapy-Induced Neuropathy Experimental- Heat application, Experimental-Cold application - Chemotherapy-Induced Peripheral Neuropathy (CIPN) | Not applicable | Completed | Bilecik Seyh Edebali Universitesi | 108 | 2025-03-03 | 2025-07-18 |
| AK135 in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN) AK135 - Chemotherapy-induced Peripheral Neuropathy (CIPN) | Phase 1 | Not yet recruiting | Akeso | 85 | 2025-02-28 | 2025-03-06 |
| Efficacy of External Application of Rosemary Oil in Patients With Chemotherapy-Induced Peripheral Neuropathy: a Feasibility Study Rosemary oil application - Chemotherapy-induced Peripheral Neuropathy (CIPN) | Not applicable | Completed | ARCIM Institute Academic Research in Complementary and Integrative Medicine | 15 | 2024-01-18 | 2025-06-04 |
| Glove Compression for Chemotherapy-Induced Neuropathy Surgical Glove Compression - Chemotherapy-induced Peripheral Neuropathy (CIPN), Gynecologic Cancers | Not applicable | Completed | Ankara Etlik City Hospital | 76 | 2024-01-01 | 2025-08-06 |
| SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN) SON-080 - Chemotherapy-induced Peripheral Neuropathy (CIPN) | Phase 1 / Phase 2 | Terminated | Sonnet BioTherapeutics | 9 | 2022-10-27 | 2024-04-12 |
| Chinese Medicinal Component Relieves CIPN and Mitochondria Function Moutan cortex, sham moutan cortex - Breast Cancer, Chemotherapy-induced Peripheral Neuropathy (CIPN) | Not applicable | Withdrawn | Taiwan Municipal An-Nan Hospital-China Medical University | 2022-08-01 | 2026-07-09 |
Showing 20 of 27. Sign in to see all of them.
Neuralgia (7) · Breast Neoplasms (6) · Neoplasms (3) · Hypothermia (2) · Muscle Weakness (2) · Peripheral Nervous System Diseases (2) · Agnosia (1) · Alopecia (1) · Cancer Pain (1) · Colorectal Neoplasms (1) · Endometrial Neoplasms (1) · Ovarian Neoplasms (1)
Nervous System Diseases (11) · Pathological Conditions, Signs and Symptoms (11) · Signs and Symptoms (11) · Neurologic Manifestations (9) · Neuromuscular Diseases (9) · Neoplasms (7) · Neoplasms by Site (7) · Pain (7) · Peripheral Nervous System Diseases (7) · Skin Diseases (7) · Skin and Connective Tissue Diseases (7) · Breast Diseases (6) · Body Temperature Changes (2) · Muscular Diseases (2) · Musculoskeletal Diseases (2)
Acupuncture Therapy (4) · Electroacupuncture (1) · Exercise (1) · Injections (1) · Observation (1) · Resistance Training (1) · Spinal Cord Stimulation (1) · moutan cortex (1)
Taiwan Municipal An-Nan Hospital-China Medical University (3) · Bilecik Seyh Edebali Universitesi (2) · National University Hospital, Singapore (2) · ARCIM Institute Academic Research in Complementary and Integrative Medicine (1) · Akeso (1) · AnHorn Medicines Co. Ltd. (1) · Ankara Etlik City Hospital (1) · Assistance Publique Hopitaux De Marseille (1) · Cairo University (1) · China Medical University Hospital (1) · Dana-Farber Cancer Institute (1) · European Institute of Oncology (1) · Johns Hopkins University (1) · Qilu Pharmaceutical Co., Ltd. (1) · Seoul National University Bundang Hospital (1)
Taiwan (6) · China (4) · United States (4) · Turkey (Türkiye) (3) · Italy (2) · Australia (1) · Canada (1) · Egypt (1) · France (1) · Germany (1) · Singapore (1) · South Korea (1)
Yi-Hung Chen, Ph.D. (2) · Amanda Chan (1) · Chao Hsing Yeh (1) · Eun Joo Yang, MD, PhD (1) · I-Ting Lee (1) · Jan Vagedes, Dr. (1) · Raghav Sundar (1) · Richard Kenney, MD (1) · Weidong Lu, M.B., MPH, Ph.D (1)
PMID 32297442, PMID 37423882, PMID 42311202
2017 (1)